Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.60 | N/A |
| PEG Ratio (TTM) | 3.89 | N/A |
| P/S Ratio (TTM) | 3.09 | N/A |
| P/B Ratio (TTM) | 4.54 | N/A |
| P/FCF Ratio (TTM) | 23.51 | N/A |
| Price to 5YR AVG Earnings Ratio | 29.20 | N/A |
| Price to 5YR AVG FCF Ratio | 29.56 | N/A |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 13.07% | N/A |
| ROE (TTM) | 29.22% | N/A |
| Net Profit Margin (TTM) | 18.63% | N/A |
| ROIC 5YR AVG | 17.16% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 21.38% | 29.72% | 17.20% |
| Revenue | -1.92% | 4.68% | 4.16% |
| Net Income | 20.85% | 28.04% | 15.63% |
| Cash Flow | 19.79% | 12.55% | 15.14% |
Health (68%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.57 | N/A |
| Quick Ratio (TTM) | 1.06 | N/A |
| D/E Ratio (TTM) | 0.59 | N/A |
| Interest Coverage (TTM) | 10.31 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 5.31 | N/A |
| LTL to 5YR AVG FCF | 3.62 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.37% | N/A |